The global deep brain stimulation market size reached US$ 1.3 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 2.6 Billion by 2032, exhibiting a growth rate (CAGR) of 8.0% during 2023-2032. The rising occurrence of various motor and neurological disorders among the masses, growing acceptance of minimally invasive (MI) surgical methods, and construction of hospitals, nursing homes, and clinics across the globe represent some of the key factors driving the market.
Deep brain stimulation (DBS) refers to the surgical procedure that aids in treating various neurological and movement-associated disorders, such as Parkinson's disease, epilepsy, dystonia, and obsessive-compulsive disorder (OCD). It involves implanting electrodes within certain areas of the brain to produce electrical impulses for regulating abnormal impulses in the brain. It relies on a pacemaker-like device, called a programmable generator, placed under the skin of the upper chest of the patient along with a wire that connects the device to the electrodes. It blocks the formation of neurological dysfunction, causing impulses, and aids the brain in functioning effectively. It helps patients handle tremors, stiffness, and dyskinesias without fully relying on high doses of medications. It is employed in the treatment of Tourette syndrome, Huntington's disease, chorea, cluster headaches, and chronic pain. It is also utilized when medications are no longer effective for patients in maintaining a good quality of life. Furthermore, as DBS directly alters brain activity in a controlled manner, it is recommended by neurosurgeons, neurologists, neuropsychologists, and psychiatrists around the world.
Deep brain stimulation (DBS) refers to the surgical procedure that aids in treating various neurological and movement-associated disorders, such as Parkinson's disease, epilepsy, dystonia, and obsessive-compulsive disorder (OCD). It involves implanting electrodes within certain areas of the brain to produce electrical impulses for regulating abnormal impulses in the brain. It relies on a pacemaker-like device, called a programmable generator, placed under the skin of the upper chest of the patient along with a wire that connects the device to the electrodes. It blocks the formation of neurological dysfunction, causing impulses, and aids the brain in functioning effectively. It helps patients handle tremors, stiffness, and dyskinesias without fully relying on high doses of medications. It is employed in the treatment of Tourette syndrome, Huntington's disease, chorea, cluster headaches, and chronic pain. It is also utilized when medications are no longer effective for patients in maintaining a good quality of life. Furthermore, as DBS directly alters brain activity in a controlled manner, it is recommended by neurosurgeons, neurologists, neuropsychologists, and psychiatrists around the world.
Deep Brain Stimulation Market Trends:
At present, the increasing demand for DBS due to the rising occurrence of various motor and neurological disorders among the masses represents one of the primary factors influencing the market positively. Besides this, the growing acceptance of minimally invasive (MI) surgical methods to reduce post-operative scarring, minimize the cost of medical bills, and decrease the duration of hospital stays is offering a favorable market outlook. Additionally, there is an increase in the construction of hospitals, nursing homes, and clinics to provide quality healthcare services to patients across the globe. This, along with the rising number of advancements made in improving the treatment and diagnosis of various neurological and psychological disorders, is propelling the growth of the market. Apart from this, the increasing awareness about the benefits of DBS and early detection of neurological complications, along with the rising geriatric population worldwide, is supporting the growth of the market. In addition, the rising occurrence of various lifestyle disorders and hypertension-induced depression among working individuals is strengthening the market growth. Moreover, key market players are incorporating artificial intelligence (AI) and the internet of things (IoT) in DBS systems to create robot-assisted implantations and multitarget stimulations.Key Market Segmentation:
The publisher provides an analysis of the key trends in each segment of the global deep brain stimulation market report, along with forecasts at the global and regional level from 2024-2032. The report has categorized the market based on stimulation type, product, application, and end-user.Stimulation Type Insights:
- Subthalamic DBS
- Globus Pallidus DBS
- Thalamic DBS
- Pedunculopontine Nucleus DBS
Product Insights:
- Single Channel Deep Brain Stimulator
- Dual Channel Deep Brain Stimulator
Application Insights:
- Parkinson's Disease (PD)
- Epilepsy
- Dystonia
- Obsessive Compulsive Disorder (OCD)
- Others
End-User Insights:
- Hospitals
- Ambulatory Surgical Centers
- Neurological Centers
- Others
Regional Insights:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global deep brain stimulation market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boston Scientific, Medtronic, St. Jude Medical, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace, Neuro Sigma, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.Key Questions Answered in This Report:
- How has the global deep brain stimulation market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global deep brain stimulation market?
- What is the impact of each driver, restraint, and opportunity on the global deep brain stimulation market?
- What are the key regional markets?
- Which countries represent the most attractive deep brain stimulation market?
- What is the breakup of the market based on the stimulation type?
- Which is the most attractive stimulation type in the deep brain stimulation market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the deep brain stimulation market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the deep brain stimulation market?
- What is the breakup of the market based on the end-user?
- Which is the most attractive end-user in the deep brain stimulation market?
- What is the competitive structure of the global deep brain stimulation market?
- Who are the key players/companies in the global deep brain stimulation market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Deep Brain Stimulation Market
6 Market Breakup by Stimulation Type
7 Market Breakup by Product
8 Market Breakup by Application
9 Market Breakup by End-User
10 Market Breakup by Region
11 SWOT Analysis
13 Porter’s Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Boston Scientific
- Medtronic
- St. Jude Medical
- Aleva Neurotherapeutics
- Beijing Pins Medical
- NeuroPace and Neuro Sigma
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 135 |
Published | March 2024 |
Forecast Period | 2023 - 2032 |
Estimated Market Value ( USD | $ 1.3 Billion |
Forecasted Market Value ( USD | $ 2.6 Billion |
Compound Annual Growth Rate | 8.0% |
Regions Covered | Global |
No. of Companies Mentioned | 6 |